(0.20%) 5 532.75 points
(0.17%) 39 537 points
(0.15%) 19 958 points
(0.80%) $82.19
(-0.85%) $2.58
(-0.21%) $2 334.60
(-0.47%) $29.42
(-0.37%) $1 010.30
(-0.36%) $0.930
(-0.50%) $10.62
(-0.15%) $0.789
(1.63%) $87.12
Live Chart Being Loaded With Signals
Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries...
Stats | |
---|---|
本日の出来高 | 751 902 |
平均出来高 | 3.12M |
時価総額 | 6.34M |
EPS | $-0.000400 ( Q4 | 2023-12-31 ) |
次の収益日 | ( $0 ) 2024-08-28 |
Last Dividend | $0.0154 ( 1997-05-19 ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 0 (Industry) 0 |
ATR14 | $0 (0.00%) |
Avecho Biotechnology Ltd 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Avecho Biotechnology Ltd 財務諸表
Annual | 2023 |
収益: | $473 551 |
総利益: | $-222 490 (-46.98 %) |
EPS: | $-0.00150 |
FY | 2023 |
収益: | $473 551 |
総利益: | $-222 490 (-46.98 %) |
EPS: | $-0.00150 |
FY | 2022 |
収益: | $1.13M |
総利益: | $793 118 (70.23 %) |
EPS: | $-0.00130 |
FY | 2021 |
収益: | $1.06M |
総利益: | $677 486 (63.94 %) |
EPS: | $-0.00324 |
Financial Reports:
No articles found.
Avecho Biotechnology Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0154 | 1995-10-25 |
Last Dividend | $0.0154 | 1997-05-19 |
Next Dividend | $0 | N/A |
Payout Date | 1997-06-06 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | $0.0308 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.22 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
1995 | $0 | 0.00% |
1996 | $0 | 0.00% |
1997 | $0 | 0.00% |
1998 | $0 | 0.00% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0 | 0.00% |
2004 | $0 | 0.00% |
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
19 May 1997 | $0.0154 | 12 Mar 1997 | 20 May 1997 | 06 Jun 1997 |
25 Oct 1995 | $0.0154 | 30 Jun 1995 | 31 Oct 1995 | 24 Nov 1995 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
EZL.AX | Dividend Royal | 2024-02-02 | Semi-Annually | 24 | 11.64% | 8.24 |
GRR.AX | Dividend Royal | 2024-03-12 | Semi-Annually | 14 | 11.88% | 7.99 |
RKN.AX | Dividend Royal | 2023-08-31 | Annually | 22 | 15.73% | 7.24 |
TWR.AX | Dividend King | 2024-06-12 | Annually | 25 | 5.98% | 7.21 |
YAL.AX | Dividend Royal | 2024-03-12 | Annually | 7 | 12.76% | 7.18 |
SHM.AX | Dividend Royal | 2024-03-14 | Semi-Annually | 9 | 14.97% | 7.14 |
HZN.AX | Dividend Royal | 2024-04-18 | Semi-Annually | 4 | 18.99% | 7.06 |
BHP.AX | Dividend Royal | 2024-03-07 | Semi-Annually | 37 | 6.46% | 6.97 |
CDD.AX | Ex Dividend King | 2024-05-24 | Annually | 21 | 91.43% | 6.79 |
KSL.AX | Dividend Royal | 2024-03-05 | Semi-Annually | 9 | 9.58% | 6.77 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -7.26 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.470 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.802 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 8.30 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 7.83 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 6.53 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0239 | -1.500 | 9.60 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -298.85 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.00100 | 2.00 | -0.000334 | -0.000669 | [0 - 30] |
freeCashFlowPerShareTTM | -0.00100 | 2.00 | -0.000502 | -0.00100 | [0 - 20] |
debtEquityRatioTTM | 0.0275 | -1.500 | 9.89 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | -0.470 | 1.000 | -10.00 | -10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -9.69 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -18.16 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.0647 | 0.800 | -2.90 | -2.32 | [0.5 - 2] |
Total Score | -2.73 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -1.844 | 1.000 | -0.287 | 0 | [1 - 100] |
returnOnEquityTTM | -0.802 | 2.50 | -6.44 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.00100 | 2.00 | -0.000334 | -0.00100 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.00100 | 2.00 | -0.000334 | -0.000669 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0170 | 1.500 | -3.45 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -6.72 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -2.55 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Avecho Biotechnology Ltd
Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It also provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney to conduct a study to examine whether topically applied cannabidiol can provide relief from symptoms of osteoarthritis. It serves customers in Australia, Switzerland, India, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。